We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
-9.08%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$23.2B
AUM Growth
-$3.45B
Cap. Flow
-$7.17B
Cap. Flow %
-30.93%
Top 10 Hldgs %
18.24%
Holding
1,260
New
101
Increased
295
Reduced
128
Closed
108
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COVAU
1001
DELISTED
COVA Acquisition Corp. Unit
COVAU
-50,000
Closed -$494K
SWAGU
1002
DELISTED
Software Acquisition Group Inc. III Unit
SWAGU
-400,000
Closed -$4.24M
COHR
1003
DELISTED
Coherent Inc
COHR
-12,000
Closed -$3.28M
PLAN
1004
DELISTED
Anaplan, Inc.
PLAN
-20,000
Closed -$1.3M
VGII.U
1005
DELISTED
Virgin Group Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fifth
VGII.U
-100,000
Closed -$992K
TCACU
1006
DELISTED
Tuatara Capital Acquisition Corporation Unit
TCACU
-500,000
Closed -$5.01M
CERN
1007
DELISTED
Cerner Corp
CERN
-131,500
Closed -$12.3M
DCUE
1008
DELISTED
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
-407,437
Closed -$41.4M
HYACU
1009
DELISTED
Haymaker Acquisition Corp. III Unit
HYACU
-18,326
Closed -$182K
ZNGA
1010
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
-695,000
Closed -$6.42M
ARTA
1011
DELISTED
Artisan Acquisition Corp. Class A Ordinary Shares
ARTA
-600,000
Closed -$5.92M
ARTAW
1012
DELISTED
Artisan Acquisition Corp. Warrants
ARTAW
-200,000
Closed -$54K
AVTR.PRA
1013
DELISTED
Avantor, Inc. Series A Mandatory Convertible Preferred Stock
AVTR.PRA
-1,067,690
Closed -$111M
XENT
1014
DELISTED
Intersect ENT, Inc
XENT
-219,732
Closed -$6.16M
DHR.PRA
1015
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
-50,498
Closed -$98.6M
WTRU
1016
DELISTED
Essential Utilities, Inc.6.00% Tangible Equity Units
WTRU
-309,382
Closed -$18.9M
TRONU
1017
DELISTED
Corner Growth Acquisition Corp. 2 Units
TRONU
-125,000
Closed -$1.25M
BHVN
1018
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-27,800
Closed -$3.3M

Similar funds

Calamos Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Calamos Advisors held 1,260 positions worth $23.2B, down 13% from $26.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Calamos Advisors withdrew a net $7.17B in Q2 2022, closing 108 positions and reducing 128 holdings. Its most notable exit was Avantor, Inc. Series A Mandatory Convertible Preferred Stock, an estimated $111M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Calamos Advisors opened a new position in Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B worth $32.5M.

  • Calamos Advisors's largest Q2 2022 buy was Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B: 24,529 shares worth $32.5M.
  • Calamos Advisors added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $285M increase.
  • Calamos Advisors's biggest Q2 2022 reduction was Bank of America, cutting an estimated $24.1M.
  • Calamos Advisors fully exited Avantor, Inc. Series A Mandatory Convertible Preferred Stock in Q2 2022, selling an estimated $111M.
  • Calamos Advisors's ten largest holdings make up 18% of its $23.2B portfolio in Q2 2022.
  • Calamos Advisors opened 101 new positions and closed 108 in Q2 2022.
  • Calamos Advisors's portfolio value fell 13% quarter-over-quarter to $23.2B.

Based on Calamos Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.